Are we underestimating seroprevalence of SARS-CoV-2?

Editorial notes considerable variation has been observed in the results of SARS-CoV-2 seroprevalence studies and current antibody tests may fail to identify people who had mild infections. Standardised approaches are required so seroprevalence estimates are comparable.

British Medical Journal